- Report
- August 2024
- 173 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- March 2025
- 174 Pages
Global
From €5201EUR$5,450USD£4,358GBP
From €2386EUR$2,500USD£1,999GBP
Point-of-care (POC) hematology diagnostics refers to the medical practice where hematology tests are conducted near the site of patient care to provide immediate results and thus facilitate rapid clinical decisions. These diagnostics include a range of tests that can evaluate blood composition, including blood count, hemoglobin levels, and coagulation status. POC hematology devices are typically smaller, portable, and designed to be user-friendly, allowing for usage outside traditional laboratory settings, such as in clinics, ambulatory care, or field environments. This sector of point-of-care diagnostics is important for managing a variety of conditions, including anemia, leukemia, and clotting disorders. The technology is especially useful in emergency medicine, critical care, and primary care settings where time-sensitive decisions are crucial for patient outcomes.
Companies that are active in the POC hematology diagnostics market provide a range of diagnostic devices and reagents. Some prominent players in this market include Abbott, Danaher (through its subsidiary Beckman Coulter), Siemens Healthineers, and Sysmex. Several of these companies offer compact analyzers suited for rapid blood tests. Other firms focus on developing innovative technologies that aim to further reduce testing time and enhance the mobility of hematology testing equipment. Show Less Read more